TriSalus Life Sciences (TLSI) Long-Term Investments (2020 - 2023)

TriSalus Life Sciences' Long-Term Investments history runs 4 years deep, the most recent figure standing at $12.1 million for Q2 2023.

• In Q2 2023, Long-Term Investments fell 95.18% year-over-year to $12.1 million; the TTM figure through Jun 2023 stood at $12.1 million (down 95.18% YoY), while the FY2022 annual figure was $19.8 million, down 92.07% from the prior year.
• Long-Term Investments for Q2 2023 stood at $12.1 million, down from $20.2 million in the prior quarter.
• The five-year high for Long-Term Investments was $251.0 million in Q3 2022, with the low at $12.1 million in Q2 2023.
• The 4-year median for Long-Term Investments is $250.0 million (2021), against an average of $186.7 million.
• The sharpest annual moves came in 2022 and 2023: Long-Term Investments climbed 0.38% in 2022, then sank 95.18% in 2023.
• TriSalus Life Sciences' Long-Term Investments stood at $250.0 million in 2020, then gained by 0.0% to $250.0 million in 2021, then tumbled by 92.07% to $19.8 million in 2022, then slumped by 39.09% to $12.1 million in 2023.
• Business Quant data shows TLSI's Long-Term Investments at $12.1 million in Q2 2023, $20.2 million in Q1 2023, and $19.8 million in Q4 2022.